| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157874 Modifier of immunology response; induce biosynthesis of cytokines; viricides; antitumor agents; anticancer agents |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157863 Triazolopyrimidines |
| 08/12/2004 | US20040157854 CCRS antagonists useful for treating aids |
| 08/12/2004 | US20040157848 effective in treating the symptoms arising from outbreaks of HSV infections, as well as methods of eliminating the virus from the body |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157840 Rifalazil compositions and therapeutic regimens |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157825 Quinolone carboxylic acid compositions and related methods of treatment |
| 08/12/2004 | US20040157821 Sulfate of cephem compound |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157769 Stabilized pharmaceutical composition in lyophilized form |
| 08/12/2004 | US20040157311 isolatable from turkeys in the field; makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from infection |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157212 to suitable titer on Vero cells, without prior adaptation; shows reactivity in an immuno-fluorescence-technique (IFT) with a polyclonal antiserum raised against a reovirus; for vaccines |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156925 Plant proanthocyanidin extract effective at inhibiting utility |
| 08/12/2004 | US20040156913 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156871 hydrophilic/hydrophobic solubilizer such as polyoxyethanyl-sitosterol sebacate, polyoxyethanyl-cholesteryl sebacate or polyoxyethanyl- alpha-tocopheryl sebacate with a polyene macrolide antibiotic or a polyunsaturated fatty acid oil |
| 08/12/2004 | US20040156868 Chicken anaemia viruses of low pathogenicity |
| 08/12/2004 | US20040156867 Proteosome influenza vaccine |
| 08/12/2004 | US20040156820 Adjuvant combination formulations |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | CA2831207A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2831202A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2812356A1 Caprazene and derivatives thereof |
| 08/12/2004 | CA2773659A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2726147A1 Caprazene and derivatives thereof |
| 08/12/2004 | CA2514560A1 Composition for preventive treatment of cold sores |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2514330A1 Mucosal meningococcal vaccines |
| 08/12/2004 | CA2513141A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 08/11/2004 | EP1445615A1 Method for discrimination between infectious and noninfectious prions |
| 08/11/2004 | EP1445327A1 Method of screening drug acting on cell wall |
| 08/11/2004 | EP1445264A1 Substance specific to pd-1 |
| 08/11/2004 | EP1444987A2 Oral vaccine against diarrhea |
| 08/11/2004 | EP1444523A2 Screening for hepatitis c virus entry inhibitors |
| 08/11/2004 | EP1444522A2 Screening for antiviral agents affecting signal peptidase |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444250A1 Groel chimeric protein and vaccine |
| 08/11/2004 | EP1444237A1 Novel c-3 s/o- and s/n formaldehe acetal derivatives of cephalo sporins and their use as antibiotics |
| 08/11/2004 | EP1444236A1 Separation of regioisomers of metal phthalocyanines |
| 08/11/2004 | EP1444223A1 Aminopyrimidines and -pyridines |
| 08/11/2004 | EP1444215A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/11/2004 | EP1443963A2 Antibody targeting compounds |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443959A1 Salmonella vaccine |
| 08/11/2004 | EP1443958A2 Vaccine against infectious disease |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443952A2 A method of reducing mortality and morbidity associated with critical illnesses |
| 08/11/2004 | EP1443950A2 A plant extract active as an immunostimulating agent |
| 08/11/2004 | EP1443944A1 Pharmaceutical applications of hyaluronic acid preparations |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443930A1 Isoxazoline derivatives useful as antimicrobials |
| 08/11/2004 | EP1443921A1 PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO 5.2.1.0 sp 2.6 /sp -DEC-9-YL XANTHOGENATE AND MEDICAMENTS THEREFROM |
| 08/11/2004 | EP1443916A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443911A1 Process for preparing quick dissolving, high loading ribavirin compositions |
| 08/11/2004 | EP1443910A1 Controlled release compositions for macrolide antimicrobial agents |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1365764A4 Oral pharmaceutical composition of cefpodoxime proxetil |
| 08/11/2004 | EP1351977B1 Antimicrobial pseudopeptides |
| 08/11/2004 | EP1345614B1 Improved and stable extract from hypericum perforatum l. , method for the production thereof and its use as a topical medicament |
| 08/11/2004 | EP1246641B1 Bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/11/2004 | EP1225904B1 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infection |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1135164B1 Composition for the treatment of inflammation |
| 08/11/2004 | EP0954288B1 Solid solution of an antifungal agent with enhanced bioavailability |
| 08/11/2004 | EP0906111B1 Composition and method for treating herpes simplex |
| 08/11/2004 | EP0839050B1 Method of enhancing cell mediated immune responses |
| 08/11/2004 | EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520412A New derivatives of oxazolidinones as antibacterial agents |
| 08/11/2004 | CN1520318A Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520308A New application of polyphenol of natural phant as well as medication and/or health products containing polyphenol of natural plant |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520295A Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519311A Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |